Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Other financing activities (2016)

Historic Other financing activities for Iradimed (IRMD) over the last 3 years, with Q4 2016 value amounting to $53122.0.

  • Iradimed's Other financing activities fell 9375.37% to $53122.0 in Q4 2016 from the same period last year, while for Dec 2016 it was $603553.0, marking a year-over-year decrease of 6508.42%. This contributed to the annual value of -$131075.0 for FY2024, which is 213849.14% down from last year.
  • As of Q4 2016, Iradimed's Other financing activities stood at $53122.0, which was down 9375.37% from $284337.0 recorded in Q3 2016.
  • In the past 5 years, Iradimed's Other financing activities registered a high of $1.8 million during Q3 2014, and its lowest value of $49807.0 during Q2 2015.
  • Over the past 3 years, Iradimed's median Other financing activities value was $209515.0 (recorded in 2016), while the average stood at $463696.8.
  • The largest annual percentage gain for Iradimed's Other financing activities in the last 5 years was 32065.37% (2016), contrasted with its biggest fall of 9375.37% (2016).
  • Iradimed's Other financing activities (Quarter) stood at $1.8 million in 2014, then tumbled by 53.81% to $850449.0 in 2015, then tumbled by 93.75% to $53122.0 in 2016.
  • Its Other financing activities stands at $53122.0 for Q4 2016, versus $284337.0 for Q3 2016 and $209515.0 for Q2 2016.